Evidence map›Paper›PMID 25225948›Full record

Observational studyAmerican journal of respiratory and critical care medicine2014

Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria.

Kondwani C Jambo, Dominic H Banda, Louise Afran, Anstead M Kankwatira, Rose D Malamba, Theresa J Allain, Stephen B Gordon, Robert S Heyderman, David G Russell, Henry C Mwandumba

Abstract readObservational Study
In one paragraph

Observational study in American journal of respiratory and critical care medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Th22 Cells Are a Major Contributor to the Mycobacterial CD4Journal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  10. Article
  11. Article
  12. HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral Eradication.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2019
    Review
  13. Article
  14. Airway CD8Frontiers in immunology · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Kondwani C Jambo1 Malawi-Liverpool-Wellcome Trust Clinical Research Programme and.
Dominic H Banda
Louise Afran
Anstead M Kankwatira
Rose D Malamba
Theresa J Allain
Stephen B Gordon
Robert S Heyderman
David G Russell
Henry C Mwandumba
University of Liverpool · GBCornell University · USLiverpool School of Tropical Medicine · GBUniversity of Malawi · MW

Funding

Restoration of alveolar macrophage function in HIV patients: A clinical study.R01HL100928 · NHLBI · CORNELL UNIVERSITY · PI RUSSELL, DAVID G · 2010 to 2014
$2.4M
Development of a Cell-Based HTS for Inhibitors of Inflammatory MacrophagesR01AI095519 · NIAID · CORNELL UNIVERSITY · PI RUSSELL, DAVID G · 2011 to 2013
$1.1M
NHLBI NIH HHS HL100928NHLBI NIH HHS R01 HL100928NIAID NIH HHS AI095519NIAID NIH HHS R01 AI095519Wellcome Trust 100890Wellcome Trust 101113
6 · The paper itself

Abstract

rationaleHIV-infected persons on antiretroviral therapy (ART) remain at higher risk of pulmonary tuberculosis (TB) than HIV-uninfected individuals. This increased susceptibility may be caused by impairment of alveolar macrophage (AM) function and/or mycobacteria-specific alveolar CD4(+) T-cell responses observed in HIV-infected ART-naive adults.

objectivesTo determine whether ART was associated with improvement in both AM function, assessed by phagosomal proteolysis, and alveolar CD4(+) T-cell responses to Mycobacterium in HIV-infected individuals.

methodsPeripheral blood was drawn and bronchoalveolar lavage (BAL) performed on healthy, 35 HIV-uninfected, 25 HIV-infected ART-naive, and 50 HIV-infected ART-treated asymptomatic adults. Phagosomal proteolysis of AM was assessed with fluorogenic beads. Mycobacteria-specific CD4(+) T-cell responses were measured by intracellular cytokine staining. MEASUREMENTS AND MAIN

resultsHIV-infected adults on ART exhibited lower plasma HIV viral load and higher blood CD4(+) T-cell count than ART-naive adults. AM proteolysis and total mycobacteria-specific Th1 CD4(+) T-cell responses in individuals on ART for greater than or equal to 4 years were similar to HIV-uninfected control subjects but those on ART for less than 4 years had impaired responses. Total influenza-specific alveolar Th1 CD4(+) T-cell responses were intact in all individuals receiving ART. In contrast, BAL and blood mycobacteria-specific polyfunctional CD4(+) T-cell responses were impaired in adults on ART irrespective of duration.

conclusionsAM and mycobacteria-specific alveolar CD4(+) T-cell responses in HIV-infected adults on ART for less than 4 years are impaired and may partly explain the high risk of TB in HIV-infected individuals on ART. Strategies to augment ART to improve lung immune cell function and reduce the high incidence of TB in HIV-infected adults who initiate ART should be investigated.

Indexed as

HIV-1AdolescentAdultAnti-HIV AgentsAsymptomatic InfectionsCase-Control StudiesCD4 Lymphocyte CountCD4-Positive T-LymphocytesCross-Sectional StudiesDrug Therapy, CombinationFemaleHIV InfectionsHumansMacrophages, AlveolarMaleMiddle AgedAnti-HIV AgentsARTHIVmacrophagesMycobacterium tuberculosisT cells

Identifiers

PMID25225948
PMCPMC4299580
OpenAlexW2072545569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.